{"id":257598,"date":"2026-09-18T15:54:08","date_gmt":"2026-09-18T10:24:08","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=257598"},"modified":"2026-09-18T15:54:08","modified_gmt":"2026-09-18T10:24:08","slug":"why-piramal-pharma-ltd-share-price-price-rise-2026-09-18","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-price-rise-2026-09-18\/","title":{"rendered":"Piramal Pharma Ltd. (PPLPHARMA): Piramal Pharma Share Price rises 2.35% to Rs 209.3; market cap at Rs 26,939.83 crore"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/pplpharma\/piramal-pharma-ltd-share-price-today\">Piramal Pharma Ltd. (PPLPHARMA)<\/a> share price rose to Rs 209.3 today, up 2.35% from the previous close. Market cap was Rs 26,939.83 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong> 18 September 2026 at 3:33:23 PM IST<\/p>\n<p style=\"margin-top:0!important;\">Piramal Pharma Share Price rose today, with the stock closing at Rs 209.3, up 2.35% from the previous close of Rs 204.5. The company\u2019s market capitalisation stood at Rs 26,939.83 crore, keeping Piramal Pharma Ltd. in focus in Healthcare and Pharmaceuticals &amp; Drugs on NSE and BSE. The move is relevant because it adds a fresh same-day share price gain to Piramal Pharma Stock News, even though the supplied data does not establish a company-specific catalyst. Univest tracks the verified price action, valuation and sector context so readers can place today\u2019s update in a broader market framework. For investors scanning Piramal Pharma Share Price Today, the main questions are simple: what changed in the session, how does the valuation compare with peers, and what do the reported financial ratios say about the company\u2019s current profile? Univest answers those questions with only verified data and without drawing on any unreported trigger, announcement or forecast.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-price-rise-2026-09-18\/#Piramal_Pharma_Share_Price_Today_Price_Action_Analysis\" title=\"Piramal Pharma Share Price Today: Price Action Analysis\">Piramal Pharma Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-price-rise-2026-09-18\/#Piramal_Pharma_Ltd_PPLPHARMA_Fundamental_Analysis\" title=\"Piramal Pharma Ltd. (PPLPHARMA) Fundamental Analysis\">Piramal Pharma Ltd. (PPLPHARMA) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-price-rise-2026-09-18\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-price-rise-2026-09-18\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-price-rise-2026-09-18\/#Why_Investors_Are_Watching_Piramal_Pharma\" title=\"Why Investors Are Watching Piramal Pharma\">Why Investors Are Watching Piramal Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-price-rise-2026-09-18\/#About_Piramal_Pharma\" title=\"About Piramal Pharma\">About Piramal Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-price-rise-2026-09-18\/#Track_Piramal_Pharma_Share_Price_on_Univest\" title=\"Track Piramal Pharma Share Price on Univest\">Track Piramal Pharma Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-price-rise-2026-09-18\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-price-rise-2026-09-18\/#Why_did_Piramal_Pharma_Share_Price_rise_today\" title=\"Why did Piramal Pharma Share Price rise today?\">Why did Piramal Pharma Share Price rise today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-price-rise-2026-09-18\/#What_is_Piramal_Pharma_Share_Price_today\" title=\"What is Piramal Pharma Share Price today?\">What is Piramal Pharma Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-price-rise-2026-09-18\/#What_is_Piramal_Pharmas_market_capitalisation\" title=\"What is Piramal Pharma\u2019s market capitalisation?\">What is Piramal Pharma\u2019s market capitalisation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-price-rise-2026-09-18\/#How_does_Piramal_Pharma_compare_with_peers_on_valuation\" title=\"How does Piramal Pharma compare with peers on valuation?\">How does Piramal Pharma compare with peers on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-price-rise-2026-09-18\/#What_do_Piramal_Pharmas_ROE_and_ROCE_show\" title=\"What do Piramal Pharma\u2019s ROE and ROCE show?\">What do Piramal Pharma\u2019s ROE and ROCE show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-price-rise-2026-09-18\/#Does_Piramal_Pharma_pay_a_dividend\" title=\"Does Piramal Pharma pay a dividend?\">Does Piramal Pharma pay a dividend?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Piramal_Pharma_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Piramal Pharma Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 209.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 204.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4.8 (+2.35%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 204.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 210<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 204.6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2.3 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 26,939.83 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/table>\n<p>Piramal Pharma Ltd. (PPLPHARMA) rose to Rs 209.3 from the previous close of Rs 204.5, a move of Rs 4.8 or 2.35%. The stock opened at Rs 204.8, reached a high of Rs 210, recorded a low of Rs 204.6.<\/p>\n<p>Piramal Pharma Ltd. (PPLPHARMA) rose to Rs 209.3 from the previous close of Rs 204.5, a move of Rs 4.8 or 2.35%. The stock opened at Rs 204.8, reached a high of Rs 210, and recorded a low of Rs 204.6. That path shows that the price stayed within a fairly tight band for most of the session before ending close to the day\u2019s high.<\/p>\n<p>Piramal Pharma Share Price Today therefore reflects a steady intraday gain rather than a sharp re-pricing. The session began just above the prior close, moved up to Rs 210, and settled at Rs 209.3, leaving the stock near the upper end of its visible range. Turnover stood at Rs 2.3 crore, which gives a basic sense of trading interest without implying anything beyond the verified update. For readers following Piramal Pharma Stock News, the key takeaway is that the stock ended stronger on the day, but the supplied data does not identify the exact driver behind the move. The market cap of Rs 26,939.83 crore adds size context to the price action and helps frame the stock\u2019s place in the sector.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Piramal_Pharma_Ltd_PPLPHARMA_Fundamental_Analysis\"><\/span><strong>Piramal Pharma Ltd. (PPLPHARMA) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 26,939.83 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.4x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-4.04%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -2.36<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 60.13<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/table>\n<p>Piramal Pharma Ltd. (PPLPHARMA) fundamental metrics show P\/B 3.4x, ROE -4.04%, ROCE 1.24%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Piramal Pharma Ltd. has a market capitalisation of Rs 26939.83 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/B at 3.4x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -4.04% and ROCE of 1.24%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs -2.36, book value per share of Rs 60.13, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 32.69x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.69x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">44.72x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.44x to 417.17x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.4x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.1x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-4.04%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.78%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.65%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 26,939.83 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 741.38 crore<\/td>\n<\/tr>\n<\/table>\n<p>Piramal Pharma Ltd. (PPLPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Piramal Pharma Ltd. (PPLPHARMA) has a ROE of -4.04%, which is below the benchmark median of 11.78%, a difference of -134.3%. Piramal Pharma Ltd. (PPLPHARMA) has a ROCE of 1.24%, which is below the benchmark median of 13.65%, a difference of -90.92%.<\/p>\n<p>Track stocks leading today through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,44,716.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">37.01<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi-s-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Divi&#39;s Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,44,223.13<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">84.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.05<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,83,453.32<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">85.3<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.73<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,10,224.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.14<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,09,848.55<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">32.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Its ROE of -4.04% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 1.24% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Piramal Pharma Ltd. (PPLPHARMA) has a market capitalisation of Rs 26,939.83 crore. Among the 5 peers shown, 5 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Piramal_Pharma\"><\/span><strong>Why Investors Are Watching Piramal Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Piramal Pharma Share Price rose 2.35% today to Rs 209.3 after opening at Rs 204.8.<\/li>\n<li>The stock\u2019s day range was Rs 204.6 to Rs 210, with turnover of Rs 2.3 crore.<\/li>\n<li>Market capitalisation stood at Rs 26,939.83 crore in the latest update.<\/li>\n<li>P\/B ratio was 3.4, compared with the sector median of 3.1 and average of 4.36.<\/li>\n<li>ROE was -4.04 and ROCE was 1.24, both below the same-industry benchmark medians.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Piramal_Pharma\"><\/span><strong>About Piramal Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Piramal Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. The supplied data does not break out business segments, revenue mix or product categories, so the company overview here stays within the verified snapshot. What is clear is that Piramal Pharma is a listed pharmaceutical business with a market capitalisation of Rs 26,939.83 crore, which places it well above the industry median in the same-industry benchmark set. Its reported book value is Rs 60.13 per share, EPS is -2.36, ROE is -4.04 and ROCE is 1.24. These figures help frame the company\u2019s position in the market. For readers tracking Piramal Pharma Stock Performance, the stock\u2019s current share price event sits alongside a business profile that reflects scale, sector membership and a mixed profitability profile. Univest publishes this company context to support factual Piramal Pharma Company News and Piramal Pharma Stock News reading.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Piramal_Pharma_Share_Price_on_Univest\"><\/span><strong>Track Piramal Pharma Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/pplpharma\/piramal-pharma-ltd-share-price-today\">Piramal Pharma Ltd. (PPLPHARMA) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top-gainers lists and related market analysis.<\/p>\n<p>Readers can track Piramal Pharma Share Price on Univest for live share price updates, key financial ratios, shareholding pattern, 52-week levels and market insights. Univest also brings together Piramal Pharma Share Price Today, Piramal Pharma Stock Analysis and Piramal Pharma Fundamental Analysis in one place so the latest data is easier to review. The platform keeps the focus on verified figures, so users can follow the stock\u2019s latest movement, valuation context and company overview without relying on unverified claims. If you are scanning Piramal Pharma Share Price Live or Piramal Pharma Latest News, Univest provides a clean way to monitor the same company, sector and peer data used in this article.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Piramal_Pharma_Share_Price_rise_today\"><\/span><strong>Why did Piramal Pharma Share Price rise today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Piramal Pharma Share Price rose 2.35% to Rs 209.3 today, but the supplied data does not establish a company-specific catalyst. The verified session shows the price move, opening range, high, low and turnover only.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Piramal_Pharma_Share_Price_today\"><\/span><strong>What is Piramal Pharma Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Piramal Pharma Share Price today is Rs 209.3. The stock gained Rs 4.8, or 2.35%, from the previous close of Rs 204.5 and finished near the day\u2019s high of Rs 210.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Piramal_Pharmas_market_capitalisation\"><\/span><strong>What is Piramal Pharma\u2019s market capitalisation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Piramal Pharma\u2019s market capitalisation is Rs 26,939.83 crore in the supplied update. That is materially above the same-industry median of Rs 741.38 crore and above the benchmark average of Rs 13,917.82 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Piramal_Pharma_compare_with_peers_on_valuation\"><\/span><strong>How does Piramal Pharma compare with peers on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Piramal Pharma\u2019s P\/B ratio is 3.4. That is below Sun Pharma, Divi&#39;s Laboratories and Torrent Pharmaceuticals, but above Cipla and slightly below Zydus Lifesciences in the supplied peer set. Its P\/B ratio is 3.4x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_Piramal_Pharmas_ROE_and_ROCE_show\"><\/span><strong>What do Piramal Pharma\u2019s ROE and ROCE show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Piramal Pharma reports ROE of -4.04 and ROCE of 1.24. Both sit below the same-industry benchmark medians, so the returns snapshot remains weaker than the sector norm in this data set.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Does_Piramal_Pharma_pay_a_dividend\"><\/span><strong>Does Piramal Pharma pay a dividend?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The dividend yield supplied for Piramal Pharma is 0. That means the current snapshot does not show a dividend contribution, while book value stands at Rs 60.13 per share and EPS is -2.36.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Piramal Pharma Ltd. Share Price rises to Rs 209.3. marking a 2.35% rise today. Market cap stands at Rs 26,939.83 crore.<\/p>\n","protected":false},"author":29,"featured_media":257597,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-257598","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["257597"],"rank_math_title":["Piramal Pharma Share Price today: price rise and valuation"],"rank_math_description":["Piramal Pharma Share Price rose 2.35% to Rs 209.3. Read the price move, valuation, sector comparison and key fundamentals behind today\u2019s update."],"rank_math_focus_keyword":["Piramal Pharma Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Piramal_Pharma_Ltd_PPLPHARMA_Piramal_Pharma_Share_Price_rises_235_to_Rs_2093_market_cap_at_Rs_2693983_crore_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/257598","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=257598"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/257598\/revisions"}],"predecessor-version":[{"id":257599,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/257598\/revisions\/257599"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/257597"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=257598"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=257598"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=257598"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}